US FDA ends pre-approval inspection of Aurobindo Pharma’s Eugia Steriles with 5 observations

Aurobindo Pharma stated that it will update the stock exchanges with further developments if necessary. Shares of Aurobindo Pharma Ltd ended at ₹1,162.55, down by ₹7.50, or 0.64%, on the BSE.